Effects of betamethasone on maternal plasma cortiocotropin releasing factor, ACTH and cortisol during pregnancy

Pamela J. Tropper, Robin S. Goland, Sharon L. Wardlaw, Harold E. Fox, Andrew G. Frantz

Research output: Contribution to journalArticle

Abstract

Corticotropin releasing factor immunoactivity (CRFi) has been identified in the plasma of women in the second half of gestation. There are several lines of evidence supporting a placental source for this hormone. Regulation of placental CRFi is poorly understood. In this study, the effect of a long-acting glucorticoid on the release of placental CRFi was investigated. Eleven women in the third trimester of pregnancy had plasma samples measured for CRFi, ACTH and cortisol before and after receiving 12 mg betamethasone. There was a significant decrease in ACTH (p <0.05) and cortisol levels (p <0.01) but no change in CRFi. It is concluded that the secretion of CRFi by the placenta is not inhibited by the administration of betamethasone while maternal levels of cortisol and ACTH are lowered. These results suggest that the acute regulation of placental CRFi is distinct from the regulation of hypothalamic CRF.

Original languageEnglish (US)
Pages (from-to)221-226
Number of pages6
JournalJournal of Perinatal Medicine
Volume15
Issue number3
DOIs
StatePublished - 1987
Externally publishedYes

Fingerprint

Betamethasone
Corticotropin-Releasing Hormone
Hydrocortisone
Mothers
Pregnancy
Adrenocorticotropic Hormone
Placental Hormones
Third Pregnancy Trimester
Placenta

Keywords

  • ACTH
  • betamethasone
  • corticotropin releasing factor
  • cortisol
  • CRF
  • glucocorticoids
  • placenta
  • preg-nancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Effects of betamethasone on maternal plasma cortiocotropin releasing factor, ACTH and cortisol during pregnancy. / Tropper, Pamela J.; Goland, Robin S.; Wardlaw, Sharon L.; Fox, Harold E.; Frantz, Andrew G.

In: Journal of Perinatal Medicine, Vol. 15, No. 3, 1987, p. 221-226.

Research output: Contribution to journalArticle

Tropper, Pamela J. ; Goland, Robin S. ; Wardlaw, Sharon L. ; Fox, Harold E. ; Frantz, Andrew G. / Effects of betamethasone on maternal plasma cortiocotropin releasing factor, ACTH and cortisol during pregnancy. In: Journal of Perinatal Medicine. 1987 ; Vol. 15, No. 3. pp. 221-226.
@article{8f681b37b6af4b5081625c86601573e8,
title = "Effects of betamethasone on maternal plasma cortiocotropin releasing factor, ACTH and cortisol during pregnancy",
abstract = "Corticotropin releasing factor immunoactivity (CRFi) has been identified in the plasma of women in the second half of gestation. There are several lines of evidence supporting a placental source for this hormone. Regulation of placental CRFi is poorly understood. In this study, the effect of a long-acting glucorticoid on the release of placental CRFi was investigated. Eleven women in the third trimester of pregnancy had plasma samples measured for CRFi, ACTH and cortisol before and after receiving 12 mg betamethasone. There was a significant decrease in ACTH (p <0.05) and cortisol levels (p <0.01) but no change in CRFi. It is concluded that the secretion of CRFi by the placenta is not inhibited by the administration of betamethasone while maternal levels of cortisol and ACTH are lowered. These results suggest that the acute regulation of placental CRFi is distinct from the regulation of hypothalamic CRF.",
keywords = "ACTH, betamethasone, corticotropin releasing factor, cortisol, CRF, glucocorticoids, placenta, preg-nancy",
author = "Tropper, {Pamela J.} and Goland, {Robin S.} and Wardlaw, {Sharon L.} and Fox, {Harold E.} and Frantz, {Andrew G.}",
year = "1987",
doi = "10.1515/jpme.1987.15.3.221",
language = "English (US)",
volume = "15",
pages = "221--226",
journal = "Journal of Perinatal Medicine",
issn = "0300-5577",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "3",

}

TY - JOUR

T1 - Effects of betamethasone on maternal plasma cortiocotropin releasing factor, ACTH and cortisol during pregnancy

AU - Tropper, Pamela J.

AU - Goland, Robin S.

AU - Wardlaw, Sharon L.

AU - Fox, Harold E.

AU - Frantz, Andrew G.

PY - 1987

Y1 - 1987

N2 - Corticotropin releasing factor immunoactivity (CRFi) has been identified in the plasma of women in the second half of gestation. There are several lines of evidence supporting a placental source for this hormone. Regulation of placental CRFi is poorly understood. In this study, the effect of a long-acting glucorticoid on the release of placental CRFi was investigated. Eleven women in the third trimester of pregnancy had plasma samples measured for CRFi, ACTH and cortisol before and after receiving 12 mg betamethasone. There was a significant decrease in ACTH (p <0.05) and cortisol levels (p <0.01) but no change in CRFi. It is concluded that the secretion of CRFi by the placenta is not inhibited by the administration of betamethasone while maternal levels of cortisol and ACTH are lowered. These results suggest that the acute regulation of placental CRFi is distinct from the regulation of hypothalamic CRF.

AB - Corticotropin releasing factor immunoactivity (CRFi) has been identified in the plasma of women in the second half of gestation. There are several lines of evidence supporting a placental source for this hormone. Regulation of placental CRFi is poorly understood. In this study, the effect of a long-acting glucorticoid on the release of placental CRFi was investigated. Eleven women in the third trimester of pregnancy had plasma samples measured for CRFi, ACTH and cortisol before and after receiving 12 mg betamethasone. There was a significant decrease in ACTH (p <0.05) and cortisol levels (p <0.01) but no change in CRFi. It is concluded that the secretion of CRFi by the placenta is not inhibited by the administration of betamethasone while maternal levels of cortisol and ACTH are lowered. These results suggest that the acute regulation of placental CRFi is distinct from the regulation of hypothalamic CRF.

KW - ACTH

KW - betamethasone

KW - corticotropin releasing factor

KW - cortisol

KW - CRF

KW - glucocorticoids

KW - placenta

KW - preg-nancy

UR - http://www.scopus.com/inward/record.url?scp=0023271221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023271221&partnerID=8YFLogxK

U2 - 10.1515/jpme.1987.15.3.221

DO - 10.1515/jpme.1987.15.3.221

M3 - Article

C2 - 2828596

AN - SCOPUS:0023271221

VL - 15

SP - 221

EP - 226

JO - Journal of Perinatal Medicine

JF - Journal of Perinatal Medicine

SN - 0300-5577

IS - 3

ER -